This systematic review aimed to assess the efficacy and safety of GLP-1 RAs in adults with obesity or overweight, by comparing different GLP-1 RAs, identifying the most effective agents, and evaluating adverse effects. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.